healthcare solutions with aptamers
NeoVentures is pleased to announce their first webinar in a series. This first webinar is entitled, Aptamers versus Antibodies in diagnostics.
NeoVentures is the global leader in aptamer development and applications. For over 18 years we have worked to improve the consistency of aptamer discovery, the validity of binding assays and most importantly the development of commercial ready aptamers.
Partnering with NeoVentures
NeoVentures does not sell a pre-set aptamer development package. Your journey with us starts with our understanding your needs for aptamer performance. We use this to develop a customized strategy for every aspect of product development from identifying the most useful aptamers, to confirming their performance and to incorporating them into commercial ready products. We build collaborations with our partners that enable us to work together dynamically to overcome hurdles to the creation of aptamer based products.